Inventor · disambiguated record
Shoshana L. Posy
Also filed as: POSY SHOSHANA L
33 granted patents·11 pending applications·133 citations·filing 2013–2024
96Inventor score
Files withBRISTOL MYERS SQUIBB CO44
Top patents by PatentIndex Score
44 records- 0196US10457681B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 29, 2019·15 cites·9 claims
- 0295US10912766B2[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 9, 2021·6 cites·17 claims
- 0395US10487084B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 26, 2019·16 cites·15 claims
- 0495US10472361B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 12, 2019·16 cites·6 claims
- 0594US10494370B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 3, 2019·15 cites·6 claims
- 0693US10047103B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 14, 2018·11 cites·22 claims
- 0792US10822343B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 3, 2020·4 cites·15 claims
- 0892US10428077B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 1, 2019·8 cites·9 claims
- 0991USRE49893E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 2, 2024·1 cites·17 claims
- 1090US9688695B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 27, 2017·11 cites·51 claims
- 1189US12162848B2Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Dec 10, 2024·1 cites·17 claims
- 1286US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 1386US10238638B2Benzothiazole and benzothiophene compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 26, 2019·4 cites·21 claims
- 1486US9862730B2Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 9, 2018·5 cites·11 claims
- 1586US9518064B2Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 13, 2016·5 cites·18 claims
- 1686US2023255941A1[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1785US11420958B2Aryl and heteroaryl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 1885US11420973B2Amide substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 1985US11306092B2Amino indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 19, 2022·3 cites·10 claims
- 2085US2025002497A1Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2182US2025163004A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2280US12084452B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 10, 2024·0 cites·6 claims
- 2379US2024190829A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2477US10723736B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·0 cites·1 claims
- 2577US10711003B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 2675US11672780B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 13, 2023·0 cites·13 claims
- 2772US10941145B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 9, 2021·0 cites·1 claims
- 2872US10927114B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 23, 2021·0 cites·1 claims
- 2972US10919895B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 16, 2021·0 cites·1 claims
- 3072US10696676B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 30, 2020·0 cites·1 claims
- 3168US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 3267US2024180886A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3367US2024207238A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3465US10981914B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 20, 2021·0 cites·2 claims
- 3564US2024228476A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3664US2024238258A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3762US2025163054A1Substituted bicyclic heteroaryl compounds useful as inhibitors of tlr9BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3860US2024317718A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3957US12384760B2Substituted carbazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 12, 2025·0 cites·13 claims
- 4054US12492188B21H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosisBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 9, 2025·0 cites·12 claims
- 4152US12172995B2Substituted indole and indazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 24, 2024·0 cites·9 claims
- 4252US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 4349US11485741B2Macrocyclic toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 4446US11878975B2Substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 23, 2024·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Shoshana L. Posy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →